Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Hirsch

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Brain : a Journal of Neurology|January 29, 2000
Preservation of midbrain catecholaminergic neurons in very old human subjectsN Kubis, B A Faucheux, G Ransmayr, et al.
Brain : a Journal of Neurology|February 17, 2007
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?Annie Lannuzel, G U Höglinger, S Verhaeghe, et al.
Annals of Neurology|December 1, 1996
Clinical and pathological features in hydrocarbon-induced parkinsonismG Pezzoli, O Strada, V Silani, et al.
Neurology|March 1, 1996
Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromesM Vila, M T Herrero, R Levy, et al.
Neuroscience|October 3, 2003
The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolismA Lannuzel, P P Michel, G U Höglinger, et al.
Annals of Neurology|December 10, 1997
Differential distribution of the normal and mutated forms of huntingtin in the human brainI Gourfinkel-An, G Cancel, Y Trottier, et al.
Neurology|July 1, 1996
Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidumM T Herrero, R Levy, M Ruberg, et al.
Trends in Neurosciences|October 29, 2000
Metabolic effects of nigrostriatal denervation in basal gangliaE C Hirsch, C Périer, G Orieux, et al.
Neuroscience|January 1, 1997
Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian statesR Levy, L N Hazrati, M T Herrero, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2000
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's diseaseA Hartmann, S Hunot, P P Michel, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Brain : a Journal of Neurology|January 29, 2000
Preservation of midbrain catecholaminergic neurons in very old human subjectsN Kubis, B A Faucheux, G Ransmayr, et al.
Brain : a Journal of Neurology|February 17, 2007
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?Annie Lannuzel, G U Höglinger, S Verhaeghe, et al.
Annals of Neurology|December 1, 1996
Clinical and pathological features in hydrocarbon-induced parkinsonismG Pezzoli, O Strada, V Silani, et al.
Neurology|March 1, 1996
Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromesM Vila, M T Herrero, R Levy, et al.
Neuroscience|October 3, 2003
The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolismA Lannuzel, P P Michel, G U Höglinger, et al.
Annals of Neurology|December 10, 1997
Differential distribution of the normal and mutated forms of huntingtin in the human brainI Gourfinkel-An, G Cancel, Y Trottier, et al.
Neurology|July 1, 1996
Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidumM T Herrero, R Levy, M Ruberg, et al.
Trends in Neurosciences|October 29, 2000
Metabolic effects of nigrostriatal denervation in basal gangliaE C Hirsch, C Périer, G Orieux, et al.
Neuroscience|January 1, 1997
Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian statesR Levy, L N Hazrati, M T Herrero, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2000
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's diseaseA Hartmann, S Hunot, P P Michel, et al.
Pageof 15